SCHEMBL821544

SCHEMBL821544

CC(=O)OCC(O)COC(=O)C(C)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.45
ALDH1A1 P00352 5/20 0.41
USP2 O75604 4/20 0.41
MAPT P10636 4/20 0.41
CYP3A4 P08684 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TP53 P04637 2/20 0.41
HPGD P15428 1/20 0.41
MEN1 O00255 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 3/20 0.39
HSD17B10 Q99714 1/20 0.39
RECQL P46063 1/20 0.35
TSHR P16473 3/20 0.34
POLB P06746 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ALOX15 P16050 1/20 0.32
PGR P06401 1/20 0.32
CHRM2 P08172 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL304203 0.88 TDP1 (0.54) TDP1ALDH1A1USP2MAPTCYP3A4
SCHEMBL15249360 0.86 TDP1 (0.45) TDP1ALDH1A1USP2MAPTCYP3A4
SCHEMBL13296152 0.83 TDP1 (0.42) TDP1ALDH1A1USP2MAPTCYP3A4
SCHEMBL6131221 0.81 TDP1 (0.48) TDP1ALDH1A1USP2MAPTCYP3A4
SCHEMBL4311541 0.81 TDP1 (0.46) TDP1ALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL19821867 0.81 TDP1 (0.41) TDP1ALDH1A1USP2MAPTCYP3A4
SCHEMBL30597601 0.81 TDP1 (0.46) TDP1ALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL9826996 0.80 TDP1 (0.44) TDP1ALDH1A1USP2MAPTCYP3A4
SCHEMBL19821836 0.79 TDP1 (0.40) TDP1ALDH1A1USP2MAPTCYP3A4
SCHEMBL23818606 0.79 TDP1 (0.47) TDP1ALDH1A1USP2MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110287102-A1 CHAIN EXTENDERS POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287102-A1 CHAIN EXTENDERS UMPS, PUF60, SMCHD1 TDP1 2133/4885ALDH1A1 333/4885USP2 419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.